Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study

被引：0
|
作者：
Philippe Cabre
M. Mejdoubi
S. Jeannin
H. Merle
Y. Plumelle
G. Cavillon
D. Smadja
R. Marignier
机构：
[1] Pierre Zobda-Quitman University Hospital,Department of Neurology
[2] Pierre Zobda-Quitman University Hospital,Department of Radiology
[3] Pierre Zobda-Quitman University Hospital,Department of Ophthalmology
[4] Pierre Zobda-Quitman University Hospital,Department of Biological Hematology
[5] Pierre-Wertheimer Hospital,Department of Neurology
[6] Civilian Hospices of Lyon,undefined
来源：
Journal of Neurology | 2018年 / 265卷
关键词：
Neuromyelitis optica; Rituximab; Treatment; Magnetic resonance imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 925
页数：8
相关论文
共 50 条
  • [1] Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
    Cabre, Philippe
    Mejdoubi, M.
    Jeannin, S.
    Merle, H.
    Plumelle, Y.
    Cavillon, G.
    Smadja, D.
    Marignier, R.
    JOURNAL OF NEUROLOGY, 2018, 265 (04) : 917 - 925
  • [2] MECHANISM OF RITUXIMAB IN THE TREATMENT OF NEUROMYELITIS OPTICA
    Yuan, Chunhua
    Liu, Ying
    Hao, Yankun
    Yan, Lei
    Liang, Jun
    Jin, Huipeng
    FARMACIA, 2022, 70 (04) : 636 - 642
  • [3] Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study
    Pietro Annovazzi
    M. Capobianco
    L. Moiola
    F. Patti
    J. Frau
    A. Uccelli
    D. Centonze
    P. Perini
    C. Tortorella
    L. Prosperini
    G. Lus
    A. Fuiani
    M. Falcini
    V. Martinelli
    G. Comi
    A. Ghezzi
    Journal of Neurology, 2016, 263 : 1727 - 1735
  • [4] Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study
    Annovazzi, Pietro
    Capobianco, M.
    Moiola, L.
    Patti, F.
    Frau, J.
    Uccelli, A.
    Centonze, D.
    Perini, P.
    Tortorella, C.
    Prosperini, L.
    Lus, G.
    Fuiani, A.
    Falcini, M.
    Martinelli, V.
    Comi, G.
    Ghezzi, A.
    JOURNAL OF NEUROLOGY, 2016, 263 (09) : 1727 - 1735
  • [5] Clinical evaluation of rituximab treatment for neuromyelitis optica
    Fernandez-Megia, M. J.
    Casanova-Estruch, B.
    Perez-Miralles, F.
    Ruiz-Ramos, J.
    Alcala-Vicente, C.
    Poveda-Andres, J. L.
    NEUROLOGIA, 2015, 30 (08): : 461 - 464
  • [6] Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study
    Meini Zhang
    Chuntao Zhang
    Peng Bai
    Huiru Xue
    Guilian Wang
    Acta Neurologica Belgica, 2017, 117 : 695 - 702
  • [7] Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study
    Zhang, Meini
    Zhang, Chuntao
    Bai, Peng
    Xue, Huiru
    Wang, Guilian
    ACTA NEUROLOGICA BELGICA, 2017, 117 (03) : 695 - 702
  • [8] Rituximab treatment in a patient with serologically proven neuromyelitis optica
    Karantoni, E.
    Evangelopoulos, M. E.
    Andreadou, E.
    Koutsis, G.
    Dimitrakopoulos, A.
    Sfagos, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 144 - 145
  • [9] Neuromyelitis optica complicating treatment of systemic lymphoma with rituximab
    Kurup, S.
    Gormley, K.
    Rudin, C.
    JOURNAL OF NEUROLOGY, 2009, 256 : S201 - S201
  • [10] Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
    McKeon, Andrew
    Pittock, Sean
    JAMA NEUROLOGY, 2013, 70 (09) : 1102 - 1104
12345